Tris Pharma Showcases a Novel Mechanism of Dual-NOP/MOP (NMR) Agonism for the …

The FDA granted Fast Track Designation to cebranopadol for chronic low back pain, and if approved, it could become the first dual-NMR pain-relief …
Source: back pain